{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 2900, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019de072-1884-72fc-abf4-6135e5b248c3", "docSlug": "22dbd55b52f7652c89bee224380ea244", "documentTitle": "Aston Martin Lagonda | Results Presentation Deck | 28 slides", "authorId": "aston-martin-lagonda", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "before_after", "function": "analyze_data", "notes": "The slide uses a waterfall chart to bridge the gap between 2020 and 2021 EBITDA, followed by a detailed EBT reconciliation table.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1884-72fc-abf4-6135e5b248c3/9", "deckHref": "/decks/019de072-1884-72fc-abf4-6135e5b248c3", "deckAnchorHref": "/decks/019de072-1884-72fc-abf4-6135e5b248c3#slide-9", "loopMatches": [ { "to": 10, "from": 9, "name": "Before After", "slug": "21-before-after", "bestFor": "Product demos, process improvements, ROI justification", "matchId": "dc4f550c-b2bc-48ed-a105-90d581dee19f", "evidence": "The presentation uses a before-after loop to highlight the company's progress.", "position": 0, "objective": "To show the significant improvement in Adjusted EBITDA and Free Cashflow", "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta", "confidence": 0.6, "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison" } ], "arcBeatMatches": [ { "to": 14, "from": 9, "beatId": "3955adc1-23c0-46aa-8dd0-430ce6e99f85", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Rising Success", "beatSlug": "rags-to-riches-rising-success", "evidence": "The presentation showcases the company's growth and progress, including its thesis headline and key messages.", "position": 2, "confidence": 0.7, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1884-72fc-abf4-6135e5b248c3", "docSlug": "22dbd55b52f7652c89bee224380ea244", "documentTitle": "Aston Martin Lagonda | Results Presentation Deck | 28 slides", "authorId": "aston-martin-lagonda", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "valuation_reveal", "function": "show_valuation_bridge", "notes": "The chart shows the reconciliation of EBT to Free Cash Flow, highlighting key drivers like D&A, Working Capital, and Investing Activities.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1884-72fc-abf4-6135e5b248c3/10", "deckHref": "/decks/019de072-1884-72fc-abf4-6135e5b248c3", "deckAnchorHref": "/decks/019de072-1884-72fc-abf4-6135e5b248c3#slide-10", "loopMatches": [ { "to": 10, "from": 9, "name": "Before After", "slug": "21-before-after", "bestFor": "Product demos, process improvements, ROI justification", "matchId": "dc4f550c-b2bc-48ed-a105-90d581dee19f", "evidence": "The presentation uses a before-after loop to highlight the company's progress.", "position": 0, "objective": "To show the significant improvement in Adjusted EBITDA and Free Cashflow", "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta", "confidence": 0.6, "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison" } ], "arcBeatMatches": [ { "to": 14, "from": 9, "beatId": "3955adc1-23c0-46aa-8dd0-430ce6e99f85", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Rising Success", "beatSlug": "rags-to-riches-rising-success", "evidence": "The presentation showcases the company's growth and progress, including its thesis headline and key messages.", "position": 2, "confidence": 0.7, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1884-72fc-abf4-6135e5b248c3", "docSlug": "22dbd55b52f7652c89bee224380ea244", "documentTitle": "Aston Martin Lagonda | Results Presentation Deck | 28 slides", "authorId": "aston-martin-lagonda", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "appendix_data", "function": "analyze_data", "notes": "The waterfall chart reconciles the cash balance from 31-Dec-20 to 31-Dec-21.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1884-72fc-abf4-6135e5b248c3/11", "deckHref": "/decks/019de072-1884-72fc-abf4-6135e5b248c3", "deckAnchorHref": "/decks/019de072-1884-72fc-abf4-6135e5b248c3#slide-11", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 9, "beatId": "3955adc1-23c0-46aa-8dd0-430ce6e99f85", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Rising Success", "beatSlug": "rags-to-riches-rising-success", "evidence": "The presentation showcases the company's growth and progress, including its thesis headline and key messages.", "position": 2, "confidence": 0.7, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1884-72fc-abf4-6135e5b248c3", "docSlug": "22dbd55b52f7652c89bee224380ea244", "documentTitle": "Aston Martin Lagonda | Results Presentation Deck | 28 slides", "authorId": "aston-martin-lagonda", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "executive_summary", "function": "summarize", "notes": "Includes a callout box regarding quarterly seasonality and specific vehicle production focus.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1884-72fc-abf4-6135e5b248c3/12", "deckHref": "/decks/019de072-1884-72fc-abf4-6135e5b248c3", "deckAnchorHref": "/decks/019de072-1884-72fc-abf4-6135e5b248c3#slide-12", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 9, "beatId": "3955adc1-23c0-46aa-8dd0-430ce6e99f85", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Rising Success", "beatSlug": "rags-to-riches-rising-success", "evidence": "The presentation showcases the company's growth and progress, including its thesis headline and key messages.", "position": 2, "confidence": 0.7, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1884-72fc-abf4-6135e5b248c3", "docSlug": "22dbd55b52f7652c89bee224380ea244", "documentTitle": "Aston Martin Lagonda | Results Presentation Deck | 28 slides", "authorId": "aston-martin-lagonda", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "cover", "function": "front_matter", "notes": "Features an Aston Martin DBX SUV as the primary visual element.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1884-72fc-abf4-6135e5b248c3/13", "deckHref": "/decks/019de072-1884-72fc-abf4-6135e5b248c3", "deckAnchorHref": "/decks/019de072-1884-72fc-abf4-6135e5b248c3#slide-13", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 9, "beatId": "3955adc1-23c0-46aa-8dd0-430ce6e99f85", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Rising Success", "beatSlug": "rags-to-riches-rising-success", "evidence": "The presentation showcases the company's growth and progress, including its thesis headline and key messages.", "position": 2, "confidence": 0.7, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1884-72fc-abf4-6135e5b248c3", "docSlug": "22dbd55b52f7652c89bee224380ea244", "documentTitle": "Aston Martin Lagonda | Results Presentation Deck | 28 slides", "authorId": "aston-martin-lagonda", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "executive_summary", "function": "summarize", "notes": "The slide uses a six-column layout to categorize operational and strategic progress.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1884-72fc-abf4-6135e5b248c3/14", "deckHref": "/decks/019de072-1884-72fc-abf4-6135e5b248c3", "deckAnchorHref": "/decks/019de072-1884-72fc-abf4-6135e5b248c3#slide-14", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 9, "beatId": "3955adc1-23c0-46aa-8dd0-430ce6e99f85", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Rising Success", "beatSlug": "rags-to-riches-rising-success", "evidence": "The presentation showcases the company's growth and progress, including its thesis headline and key messages.", "position": 2, "confidence": 0.7, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1884-72fc-abf4-6135e5b248c3", "docSlug": "22dbd55b52f7652c89bee224380ea244", "documentTitle": "Aston Martin Lagonda | Results Presentation Deck | 28 slides", "authorId": "aston-martin-lagonda", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "thesis_headline", "function": "establish_context", "notes": "The slide uses a central image of an Aston Martin SUV with four surrounding icons representing strategic pillars.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1884-72fc-abf4-6135e5b248c3/15", "deckHref": "/decks/019de072-1884-72fc-abf4-6135e5b248c3", "deckAnchorHref": "/decks/019de072-1884-72fc-abf4-6135e5b248c3#slide-15", "loopMatches": [], "arcBeatMatches": [ { "to": 21, "from": 15, "beatId": "eac4778b-71c5-4996-bf09-ed2d776fac7f", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "The Breakthrough", "beatSlug": "rags-to-riches-the-breakthrough", "evidence": "The company highlights its plans for the future, including its goals and key messages.", "position": 3, "confidence": 0.7, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1884-72fc-abf4-6135e5b248c3", "docSlug": "22dbd55b52f7652c89bee224380ea244", "documentTitle": "Aston Martin Lagonda | Results Presentation Deck | 28 slides", "authorId": "aston-martin-lagonda", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "key_messages", "function": "summarize", "notes": "The slide uses an Aston Martin F1 car as a visual anchor for brand identity.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1884-72fc-abf4-6135e5b248c3/16", "deckHref": "/decks/019de072-1884-72fc-abf4-6135e5b248c3", "deckAnchorHref": "/decks/019de072-1884-72fc-abf4-6135e5b248c3#slide-16", "loopMatches": [], "arcBeatMatches": [ { "to": 21, "from": 15, "beatId": "eac4778b-71c5-4996-bf09-ed2d776fac7f", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "The Breakthrough", "beatSlug": "rags-to-riches-the-breakthrough", "evidence": "The company highlights its plans for the future, including its goals and key messages.", "position": 3, "confidence": 0.7, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1884-72fc-abf4-6135e5b248c3", "docSlug": "22dbd55b52f7652c89bee224380ea244", "documentTitle": "Aston Martin Lagonda | Results Presentation Deck | 28 slides", "authorId": "aston-martin-lagonda", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "key_messages", "function": "summarize", "notes": "The slide uses a background image of cars on a road to visually represent the 'journey' and 'portfolio' themes.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1884-72fc-abf4-6135e5b248c3/17", "deckHref": "/decks/019de072-1884-72fc-abf4-6135e5b248c3", "deckAnchorHref": "/decks/019de072-1884-72fc-abf4-6135e5b248c3#slide-17", "loopMatches": [], "arcBeatMatches": [ { "to": 21, "from": 15, "beatId": "eac4778b-71c5-4996-bf09-ed2d776fac7f", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "The Breakthrough", "beatSlug": "rags-to-riches-the-breakthrough", "evidence": "The company highlights its plans for the future, including its goals and key messages.", "position": 3, "confidence": 0.7, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1884-72fc-abf4-6135e5b248c3", "docSlug": "22dbd55b52f7652c89bee224380ea244", "documentTitle": "Aston Martin Lagonda | Results Presentation Deck | 28 slides", "authorId": "aston-martin-lagonda", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "testimonial", "function": "illustrate_case", "notes": "Includes quotes from EVO, Autocar, Top Gear, Mr. JWW, and Carwow.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1884-72fc-abf4-6135e5b248c3/18", "deckHref": "/decks/019de072-1884-72fc-abf4-6135e5b248c3", "deckAnchorHref": "/decks/019de072-1884-72fc-abf4-6135e5b248c3#slide-18", "loopMatches": [], "arcBeatMatches": [ { "to": 21, "from": 15, "beatId": "eac4778b-71c5-4996-bf09-ed2d776fac7f", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "The Breakthrough", "beatSlug": "rags-to-riches-the-breakthrough", "evidence": "The company highlights its plans for the future, including its goals and key messages.", "position": 3, "confidence": 0.7, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1884-72fc-abf4-6135e5b248c3", "docSlug": "22dbd55b52f7652c89bee224380ea244", "documentTitle": "Aston Martin Lagonda | Results Presentation Deck | 28 slides", "authorId": "aston-martin-lagonda", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "key_messages", "function": "summarize", "notes": "The slide uses a background image of leather stitching, likely referencing the brand's craftsmanship.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1884-72fc-abf4-6135e5b248c3/19", "deckHref": "/decks/019de072-1884-72fc-abf4-6135e5b248c3", "deckAnchorHref": "/decks/019de072-1884-72fc-abf4-6135e5b248c3#slide-19", "loopMatches": [], "arcBeatMatches": [ { "to": 21, "from": 15, "beatId": "eac4778b-71c5-4996-bf09-ed2d776fac7f", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "The Breakthrough", "beatSlug": "rags-to-riches-the-breakthrough", "evidence": "The company highlights its plans for the future, including its goals and key messages.", "position": 3, "confidence": 0.7, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1884-72fc-abf4-6135e5b248c3", "docSlug": "22dbd55b52f7652c89bee224380ea244", "documentTitle": "Aston Martin Lagonda | Results Presentation Deck | 28 slides", "authorId": "aston-martin-lagonda", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "key_messages", "function": "summarize", "notes": "The slide uses a background image of a craftsman working on a luxury car seat to reinforce the 'performance-led' and 'ultra-luxury' messaging.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1884-72fc-abf4-6135e5b248c3/20", "deckHref": "/decks/019de072-1884-72fc-abf4-6135e5b248c3", "deckAnchorHref": "/decks/019de072-1884-72fc-abf4-6135e5b248c3#slide-20", "loopMatches": [], "arcBeatMatches": [ { "to": 21, "from": 15, "beatId": "eac4778b-71c5-4996-bf09-ed2d776fac7f", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "The Breakthrough", "beatSlug": "rags-to-riches-the-breakthrough", "evidence": "The company highlights its plans for the future, including its goals and key messages.", "position": 3, "confidence": 0.7, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1884-72fc-abf4-6135e5b248c3", "docSlug": "22dbd55b52f7652c89bee224380ea244", "documentTitle": "Aston Martin Lagonda | Results Presentation Deck | 28 slides", "authorId": "aston-martin-lagonda", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "key_messages", "function": "present_solution", "notes": "The slide uses a 'verb-led' strategic framework (Create, Expand, Deliver, Strengthen, Generate).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1884-72fc-abf4-6135e5b248c3/21", "deckHref": "/decks/019de072-1884-72fc-abf4-6135e5b248c3", "deckAnchorHref": "/decks/019de072-1884-72fc-abf4-6135e5b248c3#slide-21", "loopMatches": [], "arcBeatMatches": [ { "to": 21, "from": 15, "beatId": "eac4778b-71c5-4996-bf09-ed2d776fac7f", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "The Breakthrough", "beatSlug": "rags-to-riches-the-breakthrough", "evidence": "The company highlights its plans for the future, including its goals and key messages.", "position": 3, "confidence": 0.7, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1884-72fc-abf4-6135e5b248c3", "docSlug": "22dbd55b52f7652c89bee224380ea244", "documentTitle": "Aston Martin Lagonda | Results Presentation Deck | 28 slides", "authorId": "aston-martin-lagonda", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "closing_ask", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1884-72fc-abf4-6135e5b248c3/22", "deckHref": "/decks/019de072-1884-72fc-abf4-6135e5b248c3", "deckAnchorHref": "/decks/019de072-1884-72fc-abf4-6135e5b248c3#slide-22", "loopMatches": [], "arcBeatMatches": [ { "to": 28, "from": 22, "beatId": "d4629849-c746-4043-a207-9aa4f65bd367", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Ultimate Achievement", "beatSlug": "rags-to-riches-ultimate-achievement", "evidence": "The presentation concludes with a Q&A and appendix, providing additional information and disclosure.", "position": 4, "confidence": 0.7, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1884-72fc-abf4-6135e5b248c3", "docSlug": "22dbd55b52f7652c89bee224380ea244", "documentTitle": "Aston Martin Lagonda | Results Presentation Deck | 28 slides", "authorId": "aston-martin-lagonda", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "appendix", "function": "appendix", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1884-72fc-abf4-6135e5b248c3/23", "deckHref": "/decks/019de072-1884-72fc-abf4-6135e5b248c3", "deckAnchorHref": "/decks/019de072-1884-72fc-abf4-6135e5b248c3#slide-23", "loopMatches": [], "arcBeatMatches": [ { "to": 28, "from": 22, "beatId": "d4629849-c746-4043-a207-9aa4f65bd367", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Ultimate Achievement", "beatSlug": "rags-to-riches-ultimate-achievement", "evidence": "The presentation concludes with a Q&A and appendix, providing additional information and disclosure.", "position": 4, "confidence": 0.7, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1884-72fc-abf4-6135e5b248c3", "docSlug": "22dbd55b52f7652c89bee224380ea244", "documentTitle": "Aston Martin Lagonda | Results Presentation Deck | 28 slides", "authorId": "aston-martin-lagonda", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide presents a comprehensive financial overview including P&L, cash flow, and debt metrics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1884-72fc-abf4-6135e5b248c3/24", "deckHref": "/decks/019de072-1884-72fc-abf4-6135e5b248c3", "deckAnchorHref": "/decks/019de072-1884-72fc-abf4-6135e5b248c3#slide-24", "loopMatches": [], "arcBeatMatches": [ { "to": 28, "from": 22, "beatId": "d4629849-c746-4043-a207-9aa4f65bd367", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Ultimate Achievement", "beatSlug": "rags-to-riches-ultimate-achievement", "evidence": "The presentation concludes with a Q&A and appendix, providing additional information and disclosure.", "position": 4, "confidence": 0.7, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1884-72fc-abf4-6135e5b248c3", "docSlug": "22dbd55b52f7652c89bee224380ea244", "documentTitle": "Aston Martin Lagonda | Results Presentation Deck | 28 slides", "authorId": "aston-martin-lagonda", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes three distinct tables: Income Statement, Cash Flow, and EBITDA reconciliation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1884-72fc-abf4-6135e5b248c3/25", "deckHref": "/decks/019de072-1884-72fc-abf4-6135e5b248c3", "deckAnchorHref": "/decks/019de072-1884-72fc-abf4-6135e5b248c3#slide-25", "loopMatches": [], "arcBeatMatches": [ { "to": 28, "from": 22, "beatId": "d4629849-c746-4043-a207-9aa4f65bd367", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Ultimate Achievement", "beatSlug": "rags-to-riches-ultimate-achievement", "evidence": "The presentation concludes with a Q&A and appendix, providing additional information and disclosure.", "position": 4, "confidence": 0.7, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1884-72fc-abf4-6135e5b248c3", "docSlug": "22dbd55b52f7652c89bee224380ea244", "documentTitle": "Aston Martin Lagonda | Results Presentation Deck | 28 slides", "authorId": "aston-martin-lagonda", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "appendix_disclosure", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1884-72fc-abf4-6135e5b248c3/26", "deckHref": "/decks/019de072-1884-72fc-abf4-6135e5b248c3", "deckAnchorHref": "/decks/019de072-1884-72fc-abf4-6135e5b248c3#slide-26", "loopMatches": [], "arcBeatMatches": [ { "to": 28, "from": 22, "beatId": "d4629849-c746-4043-a207-9aa4f65bd367", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Ultimate Achievement", "beatSlug": "rags-to-riches-ultimate-achievement", "evidence": "The presentation concludes with a Q&A and appendix, providing additional information and disclosure.", "position": 4, "confidence": 0.7, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1884-72fc-abf4-6135e5b248c3", "docSlug": "22dbd55b52f7652c89bee224380ea244", "documentTitle": "Aston Martin Lagonda | Results Presentation Deck | 28 slides", "authorId": "aston-martin-lagonda", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "disclaimer", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1884-72fc-abf4-6135e5b248c3/27", "deckHref": "/decks/019de072-1884-72fc-abf4-6135e5b248c3", "deckAnchorHref": "/decks/019de072-1884-72fc-abf4-6135e5b248c3#slide-27", "loopMatches": [], "arcBeatMatches": [ { "to": 28, "from": 22, "beatId": "d4629849-c746-4043-a207-9aa4f65bd367", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Ultimate Achievement", "beatSlug": "rags-to-riches-ultimate-achievement", "evidence": "The presentation concludes with a Q&A and appendix, providing additional information and disclosure.", "position": 4, "confidence": 0.7, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1884-72fc-abf4-6135e5b248c3", "docSlug": "22dbd55b52f7652c89bee224380ea244", "documentTitle": "Aston Martin Lagonda | Results Presentation Deck | 28 slides", "authorId": "aston-martin-lagonda", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 28, "slideType": "closing_ask", "function": "state_next_steps", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1884-72fc-abf4-6135e5b248c3/28", "deckHref": "/decks/019de072-1884-72fc-abf4-6135e5b248c3", "deckAnchorHref": "/decks/019de072-1884-72fc-abf4-6135e5b248c3#slide-28", "loopMatches": [], "arcBeatMatches": [ { "to": 28, "from": 22, "beatId": "d4629849-c746-4043-a207-9aa4f65bd367", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Ultimate Achievement", "beatSlug": "rags-to-riches-ultimate-achievement", "evidence": "The presentation concludes with a Q&A and appendix, providing additional information and disclosure.", "position": 4, "confidence": 0.7, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1970-7036-9d15-9ffed6304914", "docSlug": "3db8307bc8c7b92a71fc075519a1ccaf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 35 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": "Includes company logo and date.", "imagePath": "https://imgproxy.kitesheet.com/LYpqk0Ex960V13CXQd4d7iA_Vdi7ROQOdtBVmqgmN4k/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zZGI4MzA3YmM4YzdiOTJhNzFmYzA3NTUxOWExY2NhZi9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1970-7036-9d15-9ffed6304914/1", "deckHref": "/decks/019de072-1970-7036-9d15-9ffed6304914", "deckAnchorHref": "/decks/019de072-1970-7036-9d15-9ffed6304914#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/7gkhnYex4hXEDIoYnBXhMnTaV6VVDuKPtsVasKICZMI/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zZGI4MzA3YmM4YzdiOTJhNzFmYzA3NTUxOWExY2NhZi9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/MBA7OJ6jJfK9Qf-Gx5e6ls3WSUQ8hcLy3UiLV5-kt70/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zZGI4MzA3YmM4YzdiOTJhNzFmYzA3NTUxOWExY2NhZi9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/0As_knInLBdlNyZq81QNbDb2iAatT_6yYoU0Whf1aiE/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zZGI4MzA3YmM4YzdiOTJhNzFmYzA3NTUxOWExY2NhZi9wMDAxLnBuZw" }, { "docId": "019de072-1970-7036-9d15-9ffed6304914", "docSlug": "3db8307bc8c7b92a71fc075519a1ccaf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 35 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1970-7036-9d15-9ffed6304914/2", "deckHref": "/decks/019de072-1970-7036-9d15-9ffed6304914", "deckAnchorHref": "/decks/019de072-1970-7036-9d15-9ffed6304914#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1970-7036-9d15-9ffed6304914", "docSlug": "3db8307bc8c7b92a71fc075519a1ccaf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 35 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "team_bio", "function": "introduce_nominees", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1970-7036-9d15-9ffed6304914/3", "deckHref": "/decks/019de072-1970-7036-9d15-9ffed6304914", "deckAnchorHref": "/decks/019de072-1970-7036-9d15-9ffed6304914#slide-3", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1970-7036-9d15-9ffed6304914", "docSlug": "3db8307bc8c7b92a71fc075519a1ccaf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 35 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "agenda", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1970-7036-9d15-9ffed6304914/4", "deckHref": "/decks/019de072-1970-7036-9d15-9ffed6304914", "deckAnchorHref": "/decks/019de072-1970-7036-9d15-9ffed6304914#slide-4", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1970-7036-9d15-9ffed6304914", "docSlug": "3db8307bc8c7b92a71fc075519a1ccaf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 35 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "cover", "function": "front_matter", "notes": "Slide 1 of a presentation deck.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1970-7036-9d15-9ffed6304914/5", "deckHref": "/decks/019de072-1970-7036-9d15-9ffed6304914", "deckAnchorHref": "/decks/019de072-1970-7036-9d15-9ffed6304914#slide-5", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1970-7036-9d15-9ffed6304914", "docSlug": "3db8307bc8c7b92a71fc075519a1ccaf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 35 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "key_messages", "function": "present_framework", "notes": "The diagram uses a circular flow to categorize drug mechanisms (Immune engagers, Cell therapy, Oncolytic virus, Immuno-oncology, DNA damage response, Antibody drug conjugates, Radioimmuno-conjugates, Nanomedicines, Epigenetics).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1970-7036-9d15-9ffed6304914/6", "deckHref": "/decks/019de072-1970-7036-9d15-9ffed6304914", "deckAnchorHref": "/decks/019de072-1970-7036-9d15-9ffed6304914#slide-6", "loopMatches": [], "arcBeatMatches": [ { "to": 7, "from": 6, "beatId": "c9f64427-f026-45db-a377-f3d329a6fa9e", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Interest", "beatSlug": "aida-interest", "evidence": "The deck generates interest by presenting key messages and takeaways from the ASCO GU 2022 conference.", "position": 3, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1970-7036-9d15-9ffed6304914", "docSlug": "3db8307bc8c7b92a71fc075519a1ccaf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 35 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "key_takeaways", "function": "summarize", "notes": "The slide categorizes the 19 abstracts into oral, mini-oral, and poster presentations, and lists three specific clinical trial highlights.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1970-7036-9d15-9ffed6304914/7", "deckHref": "/decks/019de072-1970-7036-9d15-9ffed6304914", "deckAnchorHref": "/decks/019de072-1970-7036-9d15-9ffed6304914#slide-7", "loopMatches": [], "arcBeatMatches": [ { "to": 7, "from": 6, "beatId": "c9f64427-f026-45db-a377-f3d329a6fa9e", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Interest", "beatSlug": "aida-interest", "evidence": "The deck generates interest by presenting key messages and takeaways from the ASCO GU 2022 conference.", "position": 3, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1970-7036-9d15-9ffed6304914", "docSlug": "3db8307bc8c7b92a71fc075519a1ccaf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 35 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "before_after", "function": "analyze_data", "notes": "The slide combines a Kaplan-Meier survival curve with a biological process flow diagram to support the clinical efficacy findings.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1970-7036-9d15-9ffed6304914/8", "deckHref": "/decks/019de072-1970-7036-9d15-9ffed6304914", "deckAnchorHref": "/decks/019de072-1970-7036-9d15-9ffed6304914#slide-8", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1970-7036-9d15-9ffed6304914", "docSlug": "3db8307bc8c7b92a71fc075519a1ccaf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 35 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1970-7036-9d15-9ffed6304914/9", "deckHref": "/decks/019de072-1970-7036-9d15-9ffed6304914", "deckAnchorHref": "/decks/019de072-1970-7036-9d15-9ffed6304914#slide-9", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1970-7036-9d15-9ffed6304914", "docSlug": "3db8307bc8c7b92a71fc075519a1ccaf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 35 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "appendix_methodology", "function": "present_framework", "notes": "The slide uses a standard clinical trial flow diagram (CONSORT-style).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1970-7036-9d15-9ffed6304914/10", "deckHref": "/decks/019de072-1970-7036-9d15-9ffed6304914", "deckAnchorHref": "/decks/019de072-1970-7036-9d15-9ffed6304914#slide-10", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1970-7036-9d15-9ffed6304914", "docSlug": "3db8307bc8c7b92a71fc075519a1ccaf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 35 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "comparison_table", "function": "analyze_data", "notes": "The slide demonstrates that the two study arms are well-balanced at baseline, which is a standard requirement for clinical trial validity.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1970-7036-9d15-9ffed6304914/11", "deckHref": "/decks/019de072-1970-7036-9d15-9ffed6304914", "deckAnchorHref": "/decks/019de072-1970-7036-9d15-9ffed6304914#slide-11", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1970-7036-9d15-9ffed6304914", "docSlug": "3db8307bc8c7b92a71fc075519a1ccaf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 35 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Clinical trial data presentation; includes hazard ratio and median rPFS comparison.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1970-7036-9d15-9ffed6304914/12", "deckHref": "/decks/019de072-1970-7036-9d15-9ffed6304914", "deckAnchorHref": "/decks/019de072-1970-7036-9d15-9ffed6304914#slide-12", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1970-7036-9d15-9ffed6304914", "docSlug": "3db8307bc8c7b92a71fc075519a1ccaf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 35 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "before_after", "function": "analyze_data", "notes": "The slide uses a Kaplan-Meier plot to visualize time-to-event data for a clinical trial.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1970-7036-9d15-9ffed6304914/13", "deckHref": "/decks/019de072-1970-7036-9d15-9ffed6304914", "deckAnchorHref": "/decks/019de072-1970-7036-9d15-9ffed6304914#slide-13", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1970-7036-9d15-9ffed6304914", "docSlug": "3db8307bc8c7b92a71fc075519a1ccaf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 35 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "comparison_table", "function": "analyze_data", "notes": "The slide uses a forest plot to visualize HRs and 95% CIs for multiple clinical subgroups.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1970-7036-9d15-9ffed6304914/14", "deckHref": "/decks/019de072-1970-7036-9d15-9ffed6304914", "deckAnchorHref": "/decks/019de072-1970-7036-9d15-9ffed6304914#slide-14", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1970-7036-9d15-9ffed6304914", "docSlug": "3db8307bc8c7b92a71fc075519a1ccaf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 35 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Clinical trial data presentation (Kaplan-Meier plot).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1970-7036-9d15-9ffed6304914/15", "deckHref": "/decks/019de072-1970-7036-9d15-9ffed6304914", "deckAnchorHref": "/decks/019de072-1970-7036-9d15-9ffed6304914#slide-15", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1970-7036-9d15-9ffed6304914", "docSlug": "3db8307bc8c7b92a71fc075519a1ccaf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 35 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Clinical trial data showing hazard ratios and median survival times for secondary endpoints.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1970-7036-9d15-9ffed6304914/16", "deckHref": "/decks/019de072-1970-7036-9d15-9ffed6304914", "deckAnchorHref": "/decks/019de072-1970-7036-9d15-9ffed6304914#slide-16", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1970-7036-9d15-9ffed6304914", "docSlug": "3db8307bc8c7b92a71fc075519a1ccaf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 35 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide highlights specific safety metrics including AE grades, death, and treatment modifications.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1970-7036-9d15-9ffed6304914/17", "deckHref": "/decks/019de072-1970-7036-9d15-9ffed6304914", "deckAnchorHref": "/decks/019de072-1970-7036-9d15-9ffed6304914#slide-17", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1970-7036-9d15-9ffed6304914", "docSlug": "3db8307bc8c7b92a71fc075519a1ccaf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 35 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "appendix_data", "function": "analyze_data", "notes": "SMQ = Standardised MedDRA Query; CT = computerised tomography.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1970-7036-9d15-9ffed6304914/18", "deckHref": "/decks/019de072-1970-7036-9d15-9ffed6304914", "deckAnchorHref": "/decks/019de072-1970-7036-9d15-9ffed6304914#slide-18", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1970-7036-9d15-9ffed6304914", "docSlug": "3db8307bc8c7b92a71fc075519a1ccaf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 35 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The chart uses a diverging bar structure to compare two treatment arms.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1970-7036-9d15-9ffed6304914/19", "deckHref": "/decks/019de072-1970-7036-9d15-9ffed6304914", "deckAnchorHref": "/decks/019de072-1970-7036-9d15-9ffed6304914#slide-19", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1970-7036-9d15-9ffed6304914", "docSlug": "3db8307bc8c7b92a71fc075519a1ccaf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 35 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "key_takeaways", "function": "summarize", "notes": "The slide uses color-coded text (orange) to emphasize key clinical findings.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1970-7036-9d15-9ffed6304914/20", "deckHref": "/decks/019de072-1970-7036-9d15-9ffed6304914", "deckAnchorHref": "/decks/019de072-1970-7036-9d15-9ffed6304914#slide-20", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1970-7036-9d15-9ffed6304914", "docSlug": "3db8307bc8c7b92a71fc075519a1ccaf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 35 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "section_divider", "function": "transition", "notes": "The slide features a stylized silhouette of a human figure with internal biological/molecular imagery.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1970-7036-9d15-9ffed6304914/21", "deckHref": "/decks/019de072-1970-7036-9d15-9ffed6304914", "deckAnchorHref": "/decks/019de072-1970-7036-9d15-9ffed6304914#slide-21", "loopMatches": [], "arcBeatMatches": [ { "to": 22, "from": 21, "beatId": "85580963-e5d8-46eb-92f1-48e8dc38b535", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem (Identify pain)", "beatSlug": "problem-agitate-solution-problem-identify-pain", "evidence": "The deck identifies the unmet need in mCRPC and the limitations of current treatments.", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1970-7036-9d15-9ffed6304914", "docSlug": "3db8307bc8c7b92a71fc075519a1ccaf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 35 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "customer_journey", "function": "diagnose_problem", "notes": "The slide uses a matrix-like structure to segment patients by disease stage (Hormone sensitive vs Castration resistant) and prior treatment exposure (NHA naive vs NHA experienced).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1970-7036-9d15-9ffed6304914/22", "deckHref": "/decks/019de072-1970-7036-9d15-9ffed6304914", "deckAnchorHref": "/decks/019de072-1970-7036-9d15-9ffed6304914#slide-22", "loopMatches": [], "arcBeatMatches": [ { "to": 22, "from": 21, "beatId": "85580963-e5d8-46eb-92f1-48e8dc38b535", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem (Identify pain)", "beatSlug": "problem-agitate-solution-problem-identify-pain", "evidence": "The deck identifies the unmet need in mCRPC and the limitations of current treatments.", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" }, { "to": 23, "from": 22, "beatId": "bd39fa20-160b-4166-bd23-d0d1fdebbe57", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Agitate (Make it worse)", "beatSlug": "problem-agitate-solution-agitate-make-it-worse", "evidence": "The deck highlights the consequences of not addressing the unmet need in mCRPC.", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1970-7036-9d15-9ffed6304914", "docSlug": "3db8307bc8c7b92a71fc075519a1ccaf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 35 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "key_messages", "function": "summarize", "notes": "The slide uses a three-column layout to frame the problem (left), the study design (middle), and the clinical outcomes (right).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1970-7036-9d15-9ffed6304914/23", "deckHref": "/decks/019de072-1970-7036-9d15-9ffed6304914", "deckAnchorHref": "/decks/019de072-1970-7036-9d15-9ffed6304914#slide-23", "loopMatches": [], "arcBeatMatches": [ { "to": 23, "from": 22, "beatId": "bd39fa20-160b-4166-bd23-d0d1fdebbe57", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Agitate (Make it worse)", "beatSlug": "problem-agitate-solution-agitate-make-it-worse", "evidence": "The deck highlights the consequences of not addressing the unmet need in mCRPC.", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" }, { "to": 25, "from": 23, "beatId": "7bf432cb-b1a5-4aae-a899-3cdafdfd475a", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The deck presents the PROpel trial results as a solution to the unmet need in mCRPC.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 24, "from": 23, "beatId": "9a7ec330-cddf-4aac-8d54-e948ecdab694", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Desire", "beatSlug": "aida-desire", "evidence": "The deck creates desire for the PROpel approach by highlighting its benefits and potential as a new standard of care.", "position": 4, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1970-7036-9d15-9ffed6304914", "docSlug": "3db8307bc8c7b92a71fc075519a1ccaf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 35 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "comparison_table", "function": "compare_peers", "notes": "The slide uses a patient image to humanize the clinical data. The comparison focuses on the delta (8.2m) between control/standard and experimental arms.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1970-7036-9d15-9ffed6304914/24", "deckHref": "/decks/019de072-1970-7036-9d15-9ffed6304914", "deckAnchorHref": "/decks/019de072-1970-7036-9d15-9ffed6304914#slide-24", "loopMatches": [], "arcBeatMatches": [ { "to": 25, "from": 23, "beatId": "7bf432cb-b1a5-4aae-a899-3cdafdfd475a", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The deck presents the PROpel trial results as a solution to the unmet need in mCRPC.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 24, "from": 23, "beatId": "9a7ec330-cddf-4aac-8d54-e948ecdab694", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Desire", "beatSlug": "aida-desire", "evidence": "The deck creates desire for the PROpel approach by highlighting its benefits and potential as a new standard of care.", "position": 4, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1970-7036-9d15-9ffed6304914", "docSlug": "3db8307bc8c7b92a71fc075519a1ccaf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 35 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "thesis_headline", "function": "present_solution", "notes": "The slide uses a flow-chart style diagram to segment the patient population and position the Lynparza + abiraterone combination.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1970-7036-9d15-9ffed6304914/25", "deckHref": "/decks/019de072-1970-7036-9d15-9ffed6304914", "deckAnchorHref": "/decks/019de072-1970-7036-9d15-9ffed6304914#slide-25", "loopMatches": [], "arcBeatMatches": [ { "to": 25, "from": 23, "beatId": "7bf432cb-b1a5-4aae-a899-3cdafdfd475a", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The deck presents the PROpel trial results as a solution to the unmet need in mCRPC.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1970-7036-9d15-9ffed6304914", "docSlug": "3db8307bc8c7b92a71fc075519a1ccaf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 35 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "section_divider", "function": "transition", "notes": "Slide 4 of the presentation deck.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1970-7036-9d15-9ffed6304914/26", "deckHref": "/decks/019de072-1970-7036-9d15-9ffed6304914", "deckAnchorHref": "/decks/019de072-1970-7036-9d15-9ffed6304914#slide-26", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1970-7036-9d15-9ffed6304914", "docSlug": "3db8307bc8c7b92a71fc075519a1ccaf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 35 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "key_takeaways", "function": "analyze_data", "notes": "The slide presents two distinct clinical data sets: a summary table for the BAYOU trial and a spider plot for the U105 trial.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1970-7036-9d15-9ffed6304914/27", "deckHref": "/decks/019de072-1970-7036-9d15-9ffed6304914", "deckAnchorHref": "/decks/019de072-1970-7036-9d15-9ffed6304914#slide-27", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1970-7036-9d15-9ffed6304914", "docSlug": "3db8307bc8c7b92a71fc075519a1ccaf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 35 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 28, "slideType": "closing_ask", "function": "state_next_steps", "notes": "The slide features a stylized silhouette of a human head and torso with biological/molecular imagery inside.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1970-7036-9d15-9ffed6304914/28", "deckHref": "/decks/019de072-1970-7036-9d15-9ffed6304914", "deckAnchorHref": "/decks/019de072-1970-7036-9d15-9ffed6304914#slide-28", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1970-7036-9d15-9ffed6304914", "docSlug": "3db8307bc8c7b92a71fc075519a1ccaf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 35 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 29, "slideType": "team_bio", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1970-7036-9d15-9ffed6304914/29", "deckHref": "/decks/019de072-1970-7036-9d15-9ffed6304914", "deckAnchorHref": "/decks/019de072-1970-7036-9d15-9ffed6304914#slide-29", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1970-7036-9d15-9ffed6304914", "docSlug": "3db8307bc8c7b92a71fc075519a1ccaf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 35 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 30, "slideType": "appendix", "function": "appendix", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1970-7036-9d15-9ffed6304914/30", "deckHref": "/decks/019de072-1970-7036-9d15-9ffed6304914", "deckAnchorHref": "/decks/019de072-1970-7036-9d15-9ffed6304914#slide-30", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1970-7036-9d15-9ffed6304914", "docSlug": "3db8307bc8c7b92a71fc075519a1ccaf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 35 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 31, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1970-7036-9d15-9ffed6304914/31", "deckHref": "/decks/019de072-1970-7036-9d15-9ffed6304914", "deckAnchorHref": "/decks/019de072-1970-7036-9d15-9ffed6304914#slide-31", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1970-7036-9d15-9ffed6304914", "docSlug": "3db8307bc8c7b92a71fc075519a1ccaf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 35 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 32, "slideType": "key_takeaways", "function": "analyze_data", "notes": "Includes a Kaplan-Meier curve for rPFS and a forest plot for HR by HRRm subgroup.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1970-7036-9d15-9ffed6304914/32", "deckHref": "/decks/019de072-1970-7036-9d15-9ffed6304914", "deckAnchorHref": "/decks/019de072-1970-7036-9d15-9ffed6304914#slide-32", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1970-7036-9d15-9ffed6304914", "docSlug": "3db8307bc8c7b92a71fc075519a1ccaf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 35 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 33, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Data presented as stacked bar charts showing CR, PR, SD, and PD components.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1970-7036-9d15-9ffed6304914/33", "deckHref": "/decks/019de072-1970-7036-9d15-9ffed6304914", "deckAnchorHref": "/decks/019de072-1970-7036-9d15-9ffed6304914#slide-33", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1970-7036-9d15-9ffed6304914", "docSlug": "3db8307bc8c7b92a71fc075519a1ccaf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 35 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 34, "slideType": "before_after", "function": "analyze_data", "notes": "The chart shows overlapping confidence intervals, supporting the conclusion of comparability.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1970-7036-9d15-9ffed6304914/34", "deckHref": "/decks/019de072-1970-7036-9d15-9ffed6304914", "deckAnchorHref": "/decks/019de072-1970-7036-9d15-9ffed6304914#slide-34", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1970-7036-9d15-9ffed6304914", "docSlug": "3db8307bc8c7b92a71fc075519a1ccaf", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 35 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 35, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1970-7036-9d15-9ffed6304914/35", "deckHref": "/decks/019de072-1970-7036-9d15-9ffed6304914", "deckAnchorHref": "/decks/019de072-1970-7036-9d15-9ffed6304914#slide-35", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1a15-7369-8097-68fb5b1d5017", "docSlug": "de0c004f3134112f269aa7aa17f1a1f3", "documentTitle": "AstraZeneca | Results Presentation Deck | 39 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/hfJTAZ1Y5tj6wA3pTawvgAoY-QwNUR4xGtojIJgDW2I/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kZTBjMDA0ZjMxMzQxMTJmMjY5YWE3YWExN2YxYTFmMy9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1a15-7369-8097-68fb5b1d5017/1", "deckHref": "/decks/019de072-1a15-7369-8097-68fb5b1d5017", "deckAnchorHref": "/decks/019de072-1a15-7369-8097-68fb5b1d5017#slide-1", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "a210b2f3-ce8d-436d-a281-8a1c1c211314", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "The opening remarks and key takeaways grab the audience's attention.", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": "https://imgproxy.kitesheet.com/b3yVOGKPGn7OFHv3dYLt4YmWuwScJIxK4xB7t60wVv8/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kZTBjMDA0ZjMxMzQxMTJmMjY5YWE3YWExN2YxYTFmMy9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/aHsD3TzXlppACXIWcq0OT9vUxe_sssNILtCSID2jR-o/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kZTBjMDA0ZjMxMzQxMTJmMjY5YWE3YWExN2YxYTFmMy9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/79n17j2igkFTmfyX5h2UiYTQorZObTcZAX7uwBuAFqg/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kZTBjMDA0ZjMxMzQxMTJmMjY5YWE3YWExN2YxYTFmMy9wMDAxLnBuZw" }, { "docId": "019de072-1a15-7369-8097-68fb5b1d5017", "docSlug": "de0c004f3134112f269aa7aa17f1a1f3", "documentTitle": "AstraZeneca | Results Presentation Deck | 39 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1a15-7369-8097-68fb5b1d5017/2", "deckHref": "/decks/019de072-1a15-7369-8097-68fb5b1d5017", "deckAnchorHref": "/decks/019de072-1a15-7369-8097-68fb5b1d5017#slide-2", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "a210b2f3-ce8d-436d-a281-8a1c1c211314", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "The opening remarks and key takeaways grab the audience's attention.", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1a15-7369-8097-68fb5b1d5017", "docSlug": "de0c004f3134112f269aa7aa17f1a1f3", "documentTitle": "AstraZeneca | Results Presentation Deck | 39 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "team_bio", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1a15-7369-8097-68fb5b1d5017/3", "deckHref": "/decks/019de072-1a15-7369-8097-68fb5b1d5017", "deckAnchorHref": "/decks/019de072-1a15-7369-8097-68fb5b1d5017#slide-3", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "a210b2f3-ce8d-436d-a281-8a1c1c211314", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "The opening remarks and key takeaways grab the audience's attention.", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1a15-7369-8097-68fb5b1d5017", "docSlug": "de0c004f3134112f269aa7aa17f1a1f3", "documentTitle": "AstraZeneca | Results Presentation Deck | 39 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "agenda", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1a15-7369-8097-68fb5b1d5017/4", "deckHref": "/decks/019de072-1a15-7369-8097-68fb5b1d5017", "deckAnchorHref": "/decks/019de072-1a15-7369-8097-68fb5b1d5017#slide-4", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "a210b2f3-ce8d-436d-a281-8a1c1c211314", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "The opening remarks and key takeaways grab the audience's attention.", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-1a15-7369-8097-68fb5b1d5017", "docSlug": "de0c004f3134112f269aa7aa17f1a1f3", "documentTitle": "AstraZeneca | Results Presentation Deck | 39 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-1a15-7369-8097-68fb5b1d5017/5", "deckHref": "/decks/019de072-1a15-7369-8097-68fb5b1d5017", "deckAnchorHref": "/decks/019de072-1a15-7369-8097-68fb5b1d5017#slide-5", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "a210b2f3-ce8d-436d-a281-8a1c1c211314", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "The opening remarks and key takeaways grab the audience's attention.", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }